Wet Wipes More Prevalent in Drug Development

Wet wipes and other pre-moistened applicators for topical drug administration are becoming more prevalent in drug development. Demand for nonwoven wipes used in healthcare settings is expected to increase through 2023 and demand for all types of nonwoven wipes is forecast to expand even greater. The Covid-19 pandemic has made these forecasts obsolete and points to unforeseen demand.
Patient preference and convenience are two key growth drivers for wet wipes in drug development. Recent market research conducted by AYTM market research concluded that two thirds of patients prefer wet wipes to traditional topical creams, ointments, lotions, or gels. The majority of all patients agreed with all of the following statements:
• Nonwoven wipes allow for more targeted, localized drug delivery with less potential for side effects;
• Individual packages for each wipe are more convenient and preferable to large tubes or jars;
• Nonwoven wipes are a more discrete, portable packaging for use outside of your home;
• Application with nonwoven wipes allows better limitation of application only to the area where the medicine is needed;
• Nonwoven wipes are less messy and less likely to spread to unwanted areas or get on clothes, etc.